These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8981966)

  • 21. [Relationship between methylenetetrahydrofolate reductase gene polymorphism and coronary heart disease].
    Chen B; Wang X; Yu J; Zhang G; Chen F; Den J; Fu S; Li P; Cao W; Yu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Oct; 15(5):300-2. PubMed ID: 9758879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis.
    Verhoeff BJ; Trip MD; Prins MH; Kastelein JJ; Reitsma PH
    Atherosclerosis; 1998 Nov; 141(1):161-6. PubMed ID: 9863549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homocyst(e)ine and the C677T mutation of methylenetetrahydrofolate reductase in survivors of premature myocardial infarction.
    Virgos C; Joven J; Simó JM; Vilella E; Camps J; Arcelus R; Blanco-Vaca F; Figuera L; Martorell L
    Clin Biochem; 2000 Aug; 33(6):509-12. PubMed ID: 11074245
    [No Abstract]   [Full Text] [Related]  

  • 24. Methylenetetrahydrofolate reductase mutation and coronary artery disease.
    Samani NJ
    Circulation; 1998 Dec 22-29; 98(25):2932-3. PubMed ID: 9860798
    [No Abstract]   [Full Text] [Related]  

  • 25. Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and the risk of coronary artery disease.
    Reinhardt D; Sigusch HH; Vogt SF; Farker K; Müller S; Hoffmann A
    Eur J Clin Invest; 1998 Jan; 28(1):20-3. PubMed ID: 9502183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in IDDM patients.
    Shcherbak NS; Shutskaya ZV; Sheidina AM; Larionova VI; Schwartz EI
    Mol Genet Metab; 1999 Nov; 68(3):375-8. PubMed ID: 10562465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No association between MTHFR gene polymorphism and diabetic nephropathy in Japanese type II diabetic patients with proliferative diabetic retinopathy.
    Fujita H; Narita T; Meguro H; Ishii T; Hanyu O; Suzuki K; Kamoi K; Ito S
    J Diabetes Complications; 1999; 13(5-6):284-7. PubMed ID: 10765003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperhomocysteinemia, MTHFR C677T genotype and low folate levels: a risk combination for acute coronary disease in a Portuguese population.
    Araújo F; Lopes M; Gonçalves L; Maciel MJ; Cunha-Ribeiro LM
    Thromb Haemost; 2000 Mar; 83(3):517-8. PubMed ID: 10744169
    [No Abstract]   [Full Text] [Related]  

  • 29. MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation.
    Maeda M; Yamamoto I; Fukuda M; Nishida M; Fujitsu J; Nonen S; Igarashi T; Motomura T; Inaba M; Fujio Y; Azuma J
    Diabetes Care; 2003 Feb; 26(2):547-8. PubMed ID: 12547903
    [No Abstract]   [Full Text] [Related]  

  • 30. Methionine synthase D919G mutation in type 2 diabetes and its relation to vascular events.
    Cai H; Wang X; Colagiuri S; Wilcken DE
    Diabetes Care; 1998 Oct; 21(10):1774-5. PubMed ID: 9773747
    [No Abstract]   [Full Text] [Related]  

  • 31. [The association of methylenetetrahydrofolate reductase gene polymorphism with nephropathy in type 2 diabetes mellitus in Chinese].
    Sun J; Xu Y; Zhu Y
    Zhonghua Nei Ke Za Zhi; 2001 Aug; 40(8):529-32. PubMed ID: 11718053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients.
    Neugebauer S; Baba T; Watanabe T
    Lancet; 1998 Aug; 352(9126):454. PubMed ID: 9708759
    [No Abstract]   [Full Text] [Related]  

  • 33. Methylene tetrahydrofolate reductase gene and coronary artery disease.
    Iqbal MP; Frossard PM
    J Pak Med Assoc; 2003 Jan; 53(1):33-6. PubMed ID: 12666851
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic variation of the methylenetetrahydrofolate reductase and cystathionine beta-synthase genes in Korean patients with coronary artery disease and a new polymorphism in intron 7.
    Hong SH; Song J; Kim JQ
    Mol Cell Probes; 2001 Apr; 15(2):119-23. PubMed ID: 11292330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction.
    Brugada R; Marian AJ
    Atherosclerosis; 1997 Jan; 128(1):107-12. PubMed ID: 9051203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylenetetrahydrofolate reductase 677C > T mutation and epilepsy.
    Ono H; Sakamoto A; Mizoguchi N; Sakura N
    J Inherit Metab Dis; 2000 Jul; 23(5):525-6. PubMed ID: 10947212
    [No Abstract]   [Full Text] [Related]  

  • 37. A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among U.S. men.
    Verhoef P; Rimm EB; Hunter DJ; Chen J; Willett WC; Kelsey K; Stampfer MJ
    J Am Coll Cardiol; 1998 Aug; 32(2):353-9. PubMed ID: 9708460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease.
    Wilcken DE; Wang XL; Wilcken B
    Circulation; 1997 Oct; 96(8):2738-40. PubMed ID: 9355925
    [No Abstract]   [Full Text] [Related]  

  • 39. Differences in methylenetetrahydrofolate reductase genotype frequencies, between Whites and Blacks.
    Stevenson RE; Schwartz CE; Du YZ; Adams MJ
    Am J Hum Genet; 1997 Jan; 60(1):229-30. PubMed ID: 8981967
    [No Abstract]   [Full Text] [Related]  

  • 40. Homocysteine and coronary heart disease: how great is the hazard?
    Wilson PW
    JAMA; 2002 Oct 23-30; 288(16):2042-3. PubMed ID: 12387658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.